Inventor · disambiguated record
Elina Makino
Also filed as: MAKINO ELINA
5 granted patents·11 pending applications·30 citations·filing 2013–2024
78Inventor score
Top patents by PatentIndex Score
16 records- 0192US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 0290US9139580B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Granted Sep 22, 2015·14 cites·1 claims
- 0387US9126993B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Sep 8, 2015·9 cites·1 claims
- 0486US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 0582US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 0672US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 0764US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 0859US2025144174A1Compositions, devices, and methods for treating cns disordersSIGILON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0957US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
- 1056US2025136671A1Therapies for mucopolysaccharidosis type 6SIGILON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1155US2024123040A1Compositions, devices and methods for treating mps vi diseaseSIGILON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1255US2023287341A1Genetically modified cell lines expressing an exogenous substance and uses thereofSIGILON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1353US2016207933A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2015·Application pending·0 cites
- 1449US2024209336A1Genetically modified human cell lines and uses thereofSIGILON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1546US11098056B2UDP glycosyltransferase inhibitors and methods of useGENZYME CORP·Filed 2019·Granted Aug 24, 2021·0 cites·30 claims
- 1643US2022267794A1Compositions, devices, and methods for treating fabry diseaseSIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elina Makino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →